Heelan RT - Search Results

1

A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.

Steffens TA, Bajorin DF, Chapman PB, Lovett DR, Cody-Johnson BV, Templeton MA, Heelan RT, Wong GY, Portlock CS, Oettgen HF, et al. Steffens TA, et al. Among authors: heelan rt. Cancer. 1991 Sep 15;68(6):1230-7. doi: 10.1002/1097-0142(19910915)68:6<1230::aid-cncr2820680608>3.0.co;2-q. Cancer. 1991. PMID: 1873774 Clinical Trial.

2

Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.

Kelsen D, Lovett D, Wong J, Saltz L, Buckley M, Murray P, Heelan R, Lightdale C. Kelsen D, et al. J Clin Oncol. 1992 Feb;10(2):269-74. doi: 10.1200/JCO.1992.10.2.269. J Clin Oncol. 1992. PMID: 1732428 Clinical Trial.

3

Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas.

Crown JP, Gulati S, Straus DJ, Kolitz J, Heelan R, O'Brien J, Lee BJ, Portlock C, Bertino J. Crown JP, et al. Invest New Drugs. 1991 May;9(2):185-6. doi: 10.1007/BF00175086. Invest New Drugs. 1991. PMID: 1874601 Clinical Trial.

4

Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus.

Bajorin D, Kelsen D, Heelan R. Bajorin D, et al. Cancer Treat Rep. 1986 Oct;70(10):1245-6. Cancer Treat Rep. 1986. PMID: 3530454 Clinical Trial. No abstract available.

5

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.

Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP. Ilson DH, et al. Cancer. 1995 May 1;75(9):2197-202. doi: 10.1002/1097-0142(19950501)75:9<2197::aid-cncr2820750902>3.0.co;2-s. Cancer. 1995. PMID: 7712428 Clinical Trial.

6

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.

Puc HS, Heelan R, Mazumdar M, Herr H, Scheinfeld J, Vlamis V, Bajorin DF, Bosl GJ, Mencel P, Motzer RJ. Puc HS, et al. J Clin Oncol. 1996 Feb;14(2):454-60. doi: 10.1200/JCO.1996.14.2.454. J Clin Oncol. 1996. PMID: 8636757

7

Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study.

Warrell RP Jr, Lovett D, Dilmanian FA, Schneider R, Heelan RT. Warrell RP Jr, et al. Among authors: heelan rt. J Clin Oncol. 1993 Dec;11(12):2443-50. doi: 10.1200/JCO.1993.11.12.2443. J Clin Oncol. 1993. PMID: 8246033 Clinical Trial.

8

Surgery for a post-chemotherapy residual mass in seminoma.

Herr HW, Sheinfeld J, Puc HS, Heelan R, Bajorin DF, Mencel P, Bosl GJ, Motzer RJ. Herr HW, et al. J Urol. 1997 Mar;157(3):860-2. J Urol. 1997. PMID: 9072586 Free article. Review.

9

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Among authors: heelan rt. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

10

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.

Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG, et al. Kritz A, et al. Among authors: heelan rt. Cancer. 1993 Apr 15;71(8):2515-21. doi: 10.1002/1097-0142(19930415)71:8<2515::aid-cncr2820710814>3.0.co;2-2. Cancer. 1993. PMID: 8095854 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters